SEC Filing Analysis: SUTRO BIOPHARMA, INC. (STRO)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The CEO acquired shares through a routine RSU vesting and simultaneously disposed of a portion to cover the associated tax liability. This is a non-discretionary event and not indicative of a change in insider sentiment.
• Market Impact: Neutral. The transaction is too small to impact the market and is a common practice for executive compensation.

Company Information

Field	Value
Company	SUTRO BIOPHARMA, INC.
Ticker Symbol	STRO
CIK	0001382101
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	Chung Jane
CIK	0001872398
Title/Position	Chief Executive Officer
Relationship	Director, Officer

Transaction Details

This filing reports two related non-derivative transactions following the vesting of Restricted Stock Units (RSUs).

Transaction 1: RSU Vesting

Field	Value
Transaction Date	2025-12-12
Transaction Code	M (Exercise/Vesting)
Security Type	Common Stock
Shares Involved	2,500
Price Per Share	$0.00
Total Value	$0
Type	Acquisition

Transaction 2: Tax Withholding Sale

Field	Value
Transaction Date	2025-12-12
Transaction Code	F (Withholding of securities for tax liability)
Security Type	Common Stock
Shares Involved	894
Price Per Share	$8.015
Total Value	$7,165.41
Type	Disposition
Shares Owned After	13,891
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

The analysis focuses on the tax withholding sale, as it has a market value.

Metric	Value
Transaction Value	$7,165.41
% of Market Cap	0.009%
Shares Transacted	894
% of Shares Outstanding	0.001%
Post-Transaction Ownership	13,891 shares (0.016% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: Sutro Biopharma is a small-cap company with an $80 million market capitalization. The transaction value of ~$7k is negligible in this context.
• Ownership Concentration: The CEO's post-transaction ownership of 13,891 shares represents a very small fraction (0.016%) of the total shares outstanding, indicating low ownership concentration from this holding.
• Transaction Significance: The transaction represents less than 0.01% of both market cap and shares outstanding, falling well below the threshold for even low significance. The nature of the transaction (tax withholding) further reduces its importance as a market signal.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The filing details a mandatory tax-related sale (Code 'F'), not a discretionary sale based on the insider's market outlook. Such transactions are standard procedure for equity compensation and do not typically influence stock price.

Volume & Sentiment

• Expected Volume Impact: None. The number of shares is insignificant compared to daily trading volume.
• Sentiment Indicator: Neutral. This is a routine administrative transaction, not a bullish or bearish signal.

Additional Context

Transaction Notes

• Footnote F1: The filing explicitly states, "Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations... does not represent a sale by the reporting person." This confirms the non-discretionary nature of the disposition.